Additive manufacturing, aka 3D printing, has accelerated medicine in important ways – from surgical guides and training models to patient-specific and biocomposite orthopedic implants. Thanks to continued advancements in 3D printing and our ever-increasing understanding of cells and the human body, scientists and engineers are now trying to directly manufacture biology ex vivo. Their time […]
Caralynn Nowinski-Collens, MD
Caralynn Nowinski-Collens, MD
Dr. Caralynn Nowinski Collens is the CEO of Dimension Inx, a next-generation biomaterials and biofabrication company developing 3D-printed therapeutic products that direct cells to rebuild healthy tissues. She is passionate about building teams and organizations that harness technology to drive transformational change and improve the quality of people’s lives.
Previously as the co-founder and CEO of UI LABS, a first-of-its-kind technology organization focused on the digital future of industries, Caralynn built the organization from concept in late 2011 through launch in 2014, raising $200M+ in investment and ultimately spinning out MxD (national digital manufacturing institute) and City Tech Collaborative as independent businesses in 2019. After starting her first company while a joint medical/business student at the University of Illinois at Chicago, Caralynn spent her early career in venture capital and corporate finance, primarily focused on technology-based university spin-outs.
Caralynn is an Independent Director of Fathom Digital Manufacturing [NYSE:FATH] and serves on the Executive Council of Granite Creek Capital Partners. She is proud to have been a member of the Chicago Chapter of the Young Presidents’ Organization (YPO) and recognized as one of Crain’s Chicago Business’ “Forty Under Forty”, “Notable Women in Manufacturing”, and “Tech 50”. In 2020, SME recognized Caralynn as one of “30 Leaders Transforming Manufacturing”.
